OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancerEleni Frangou, Sarah P. Blagden, René L. Roux et al.|Gynecologic Oncology|2021Cited by 22
A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignanciesSarah P. Blagden, T.R. Jeffry Evans, Essam Ghazaly et al.|Annals of Oncology|2018Cited by 2
OVPSYCH2: A randomised study of psychological support versus standard of care following chemotherapy for ovarian cancerSarah P. Blagden, L. Howells, Sharon Love et al.|Annals of Oncology|2018Cited by 1
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC)Karin Purshouse, Jeremy Crew, Vincenzo Cerundolo et al.|European Urology Supplements|2019Cited by 1